BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In this respect, it has been demonstrated, for instance, that autophagy acts as a survival signal in BCR/Abl-expressing cells treated with TKi and that its inhibition potentiates TKi-induced cell death, besides targeting the TKi-resistant SC of CML [58].